Video: Simon Estcourt of Idis on #RareDisease patients and #OrphanDrug business models

Simon Estcourt of Idis on rare disease patients and orphan drugs Simon Estcourt, Senior Vice President – Strategy & Corporate Development at Idis, presented at last year's World Orphan Drug Congress USA on the topic ‘Managing patients globally: Considerations for developing robust orphan drug business models that create ethical access.'

Do you want to learn more about:

  • Evolving ethical and commercial drivers in rare disease business considerations
  • Benefits of early strategic planning for global managed access to appropriately address needs of emerging and established markets
  • Successfully providing equitable access through global managed access strategies in pre-launch phase and post-launch

If so, you need to check out the video below:

For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!

Leave a Reply

Your email address will not be published. Required fields are marked *